Raymond James & Associates »

Tg Therapeutics shares owned by Raymond James & Associates

Quarter-by-quarter ownership of Tg Therapeutics (TGTX) shares owned by Raymond James & Associates from 13F filings

Historical chart of Raymond James & Associates investment in Tg Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tg Therapeutics held by Raymond James & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tg Therapeutics by Raymond James & Associates

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.9M 127k 15.21
2023-12-31 $2.2M 126k 17.08
2023-09-30 $1.3M 150k 8.36
2023-06-30 $3.6M 146k 24.84
2023-03-31 $2.5M 169k 15.04
2022-12-31 $2.2M 182k 11.83
2022-09-30 $1.1M 194k 5.92
2022-06-30 $751k 177k 4.25
2022-03-31 $1.6M 166k 9.51
2021-12-31 $3.0M 159k 19.00
2021-09-30 $6.0M 180k 33.28
2021-06-30 $7.6M 195k 38.79
2021-03-31 $9.9M 205k 48.20
2020-12-31 $12M 229k 52.02
2020-09-30 $5.8M 216k 26.76
2020-06-30 $4.7M 240k 19.48
2020-03-31 $2.7M 274k 9.84
2019-12-31 $3.6M 322k 11.10
2019-09-30 $1.9M 333k 5.62
2019-06-30 $2.7M 313k 8.65
2019-03-31 $3.1M 381k 8.04
2018-12-31 $1.4M 330k 4.10
2018-09-30 $1.3M 234k 5.60
2018-06-30 $1.4M 108k 13.15
2018-03-31 $3.2M 226k 14.20
2017-12-31 $1.7M 212k 8.20
2017-09-30 $1.1M 89k 11.85
2017-06-30 $839k 84k 10.05
2017-03-31 $1.2M 106k 11.65
2016-12-31 $243k 52k 4.64
2016-09-30 $183k 24k 7.75
2016-06-30 $93k 15k 6.04
2016-03-31 $117k 14k 8.53
2015-06-30 $289k 17k 16.60
2015-03-31 $295k 19k 15.47